Impetus AG Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
20
Impetus AG General Information
Description
Developer of a bi-specific plant-based pesticide designed to protect plants from harmful insects. The company offers proteins that improve crop yield by linking antibodies present within plant bodies using Bacillus thuringiensis technology, enabling farmers to have food crops that will combat the growing number of insects resistant to current commercial products and enhance product durability.
Contact Information
Website
www.impetusag.comCorporate Office
- 1100 Corporate Square Drive
- Saint Louis, MO 63132
- United States
Corporate Office
- 1100 Corporate Square Drive
- Saint Louis, MO 63132
- United States
Impetus AG Timeline
Impetus AG Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Accelerator/Incubator | 16-Apr-2026 | Completed | Generating Revenue | |||
| 9. Accelerator/Incubator | 15-Feb-2024 | Completed | Generating Revenue | |||
| 8. Later Stage VC | 22-Feb-2023 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | 11-Jul-2023 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 01-May-2023 | Completed | Generating Revenue | |||
| 5. Early Stage VC | 21-Dec-2022 | Completed | Generating Revenue | |||
| 4. Seed Round | 02-Jun-2021 | Completed | Generating Revenue | |||
| 3. Seed Round | 27-Jun-2018 | Completed | Startup | |||
| 2. Accelerator/Incubator | 07-Mar-2018 | $100K | $100K | Completed | Startup | |
| 1. Joint Venture | 01-Jan-2018 | Completed | Startup |
Impetus AG Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed 1 |
Impetus AG Patents
Impetus AG Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024278864-A1 | Insecticidal fusion polypeptides and methods for their use | Pending | 31-May-2023 | ||
| AU-2024278864-A9 | Insecticidal fusion polypeptides and methods for their use | Pending | 31-May-2023 | ||
| US-20260354386-A1 | Insecticidal fusion polypeptides and methods for their use | Pending | 31-May-2023 | ||
| WO-2024249784-A2 | Insecticidal fusion polypeptides and methods for their use | Inactive | 31-May-2023 | ||
| WO-2024249784-A3 | Insecticidal fusion polypeptides and methods for their use | Inactive | 31-May-2023 | C12N15/8286 |
Impetus AG Signals
Impetus AG Investors (20)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Harvest AgTech | Accelerator/Incubator | |||
| Radicle (San Diego) | Accelerator/Incubator | |||
| UPL Corporation | Corporation | |||
| Wells Fargo Innovation Incubator | Accelerator/Incubator | Minority | ||
| M7 Ace Neo | Venture Capital | Minority |
Impetus AG FAQs
-
When was Impetus AG founded?
Impetus AG was founded in 2018.
-
Where is Impetus AG headquartered?
Impetus AG is headquartered in Saint Louis, MO.
-
What is the size of Impetus AG?
Impetus AG has 8 total employees.
-
What industry is Impetus AG in?
Impetus AG’s primary industry is Agricultural Chemicals.
-
Is Impetus AG a private or public company?
Impetus AG is a Private company.
-
What is Impetus AG’s current revenue?
The current revenue for Impetus AG is .
-
How much funding has Impetus AG raised over time?
Impetus AG has raised $8.66M.
-
Who are Impetus AG’s investors?
Harvest AgTech, Radicle (San Diego), UPL Corporation, Wells Fargo Innovation Incubator, and M7 Ace Neo are 5 of 20 investors who have invested in Impetus AG.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process